Laketown Synergy, in partnership with Novo Nordisk, hosted an insightful medical symposium titled “Talk of the Town: The Semaglutide Way” on July 13, 2025, at ITC Royal Bengal, Kolkata. The event brought together healthcare professionals specializing in diabetes, endocrinology, and metabolic disorders to discuss the latest advancements in obesity management, with a focus on the role of Semaglutide 2.4 mg in clinical practice. The seamless coordination by Dr. Soumyabrata Roy Chaudhuri ensured a productive exchange of knowledge among speakers and attendees.
The symposium began with Dr. Ghanshyam Goyal highlighting obesity as a growing public health concern, emphasizing the need for multidisciplinary approaches to treatment. Dr. Jagat Jyoti Mukherjee followed with an overview of obesity trends, shedding light on its increasing prevalence and associated health risks.
A significant portion of the event was dedicated to exploring Semaglutide 2.4 mg and its clinical applications:
- Dr. Awadhesh Kumar Singh discussed strategies for optimizing treatment outcomes, including dosage adjustments and managing side effects.
- Dr. Prakash Kumar Hazra shared evidence on the cardiovascular benefits of Semaglutide, particularly for patients with obesity-related complications.
Practical Insights for Clinicians
The program also addressed real-world challenges in obesity management:
- Dr. Kalyan Kumar Gangopadhyay provided guidance on using Semaglutide in complex cases, such as patients with comorbidities.
- Dr. Binayak Sinha offered perspectives on emerging therapies and future directions in obesity care.
A panel discussion, moderated by Dr. Subir Ray, featured experts like Drs. Sujoy Majumdar and Sanjay K. Shah, who answered questions and shared practical tips for integrating Semaglutide into daily practice.
Laketown Synergy extends its gratitude to Novo Nordisk for their support and to Dr. Soumyabrata Roy Chaudhuri for his efforts in organizing this valuable event. The enthusiastic participation and engaging discussions underscored the importance of continued education in obesity management.
Moving forward, Laketown Synergy remains committed to fostering such collaborations and looks forward to hosting more initiatives that bridge the gap between research and clinical practice.
